Bovine Serum Albumin Encapsulation of Near Infrared Fluorescent Nano-Probe with Low Nonspecificity and Cytotoxicity for Imaging of HER2-positive Breast Cancer Cells.

Tianxiang Wei,Hong Xing,Huafeng Wang,Yuluan Zhang,Junning Wang,Jian Shen,Zhihui Dai

DOI: https://doi.org/10.1016/j.talanta.2019.120625

IF: 6.1

2020-01-01

Talanta

Abstract:Breast cancer with HER2 overexpressing type links to malignant tumor growth and poor clinical outcome. Successful development of sensitive and selective nano-probe for identification of HER2-positive breast cancer cells is of great importance for breast cancer early diagnosis, subtype classification, and treatment planning. Herein, we report a HER2 antibody conjugated near infrared (NIR) emitted MnCuInS/ZnS qumtun dots (QDs) encapsulated bovine serum albumin (BSA) nano-probe for accurately targeted imaging of HER2-positive breast cancer cells. This NIR nano-probe shows good biocompatibility, low nonspecificity and cytotoxicity, high colloidal stability, and allows HER2-positive breast cancer cell identification with good selectivity. The practicality of this targeted NIR fluorescent nano-probe was proved by successful identifying HER2-positive breast cancer cells from HER2-negative breast cancer cells, which indicates that it can be efficiently applied in selective screening of HER2 overexpressing cancer cells, and provide a platform for the strategy design on the distinction of different breast cancer subtypes.